Objective. To standardize outcome measures in systemic lupus erythematosus (SLE). Three
indices were identified which could adequately describe outcome (disease activity, damage …

OBJECTIVE: To describe the Systemic Lupus Erythematosus Disease Activity Index 2000 (SLEDAI-2K),
a modification of SLEDAI to reflect persistent, active disease in those descriptors …

Objective To develop new classification criteria for systemic lupus erythematosus ( SLE )
jointly supported by the European League Against Rheumatism ( EULAR ) and the American …

A review of the literature suggests there are two major aspects of responsiveness. We
define the first as “internal responsiveness,” which characterizes the ability of a measure to …

Objective To examine mortality rates in the largest systemic lupus erythematosus (SLE) cohort
ever assembled. Methods Our sample was a multisite international SLE cohort (23 centers…

Psoriatic arthritis occurs in up to 30% of people with psoriasis and can have serious
debilitating effects on the peripheral joints, spine, tendon insertions, and fingers …

Objective Adalimumab, a fully human, anti–tumor necrosis factor monoclonal antibody, was
evaluated for its safety and efficacy compared with placebo in the treatment of active …

To gain further insight into the genetic architecture of psoriasis, we conducted a meta-analysis
of 3 genome-wide association studies (GWAS) and 2 independent data sets genotyped …

Objective To update the 2009 Group for Research and Assessment of Psoriasis and Psoriatic
Arthritis (GRAPPA) treatment recommendations for the spectrum of manifestations affecting …

Since 1978, 220 patients with psoriatic arthritis have undergone detailed study at the Women's
College Hospital in Toronto, Canada. Clinical, radiological and biochemical data were …